Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]

7644 reported adverse events

Drugs of this class: AGALSIDASE BETA

These side effects are most commonly reported by patients taking drugs of the Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] class:

# Side effect Count
0 PYREXIA 457
1 CHILLS 433
2 PAIN 431
3 MALAISE 416
4 NAUSEA 396
5 DYSPNOEA 351
6 FATIGUE 326
7 HEADACHE 319
8 VOMITING 318
9 INFUSION RELATED REACTION 279
See all common reactions for Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]

Drugs of the Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GLOBOTRIAOSYLSPHINGOSINE INCREASED 55 0.9821
1 GLOBOTRIAOSYLCERAMIDE INCREASED 52 0.9811
2 FABRY'S DISEASE 23 0.6571
3 ANGIOKERATOMA 23 0.3151
4 ANTIBODY TEST 19 0.2639
5 DRUG SPECIFIC ANTIBODY ABSENT 19 0.1080
6 ANTIBODY TEST NEGATIVE 19 0.1056
7 NEUTRALISING ANTIBODIES POSITIVE 19 0.0576
8 RENAL TRANSPLANT 71 0.0244
9 ANTIBODY TEST POSITIVE 35 0.0232
See all enriched reactions for Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC]